Primer’s heritage yeasts are a result of many years of long interdisciplinary cooperation in the fields of archaeology, biology and the fermenting brewing industry. Together, we have combined our actions in to the goal of isolating unique vital yeast cells from a variety of “Terra Cotta” vessels, which are excavated in different geographical dig sites, from different eras in ancient history, made by some of the greatest past cultures of our civilization.
The Pilpel Seeds Company primarily focus on providing superior and unique pepper varieties to the local and international markets. Utilizing 30 years of Dr. Yonatan Elkind’s research, together with the germplasm available at the Hebrew University, The Pilpel Seeds Company is offering local and international markets a variety of pepper seeds with unique and sustainable traits that will improve the profitability of growers.
APIX Nutrition has been established by two of the worlds’ leading authorities on bee nutrition who seek to commercialize their work, and that of an international research team involving The Hebrew University of Jerusalem (Israel) and the Universities of Oxford and Newcastle (UK) that, after 7+ years’ work, has resulted in a new feed formulation for honeybees that is demonstrably superior to any of those presently on the market.
The Company produces biologically active recombinant proteins (mainly different cytokines and their soluble receptors), in E. coli, a know-how developed by Prof. Gertler during the last 20 years and unconditionally licensed to The Company by The Hebrew University and Yissum Co. PLR also has the know how to produce expression plasmids and recombinant proteins upon request. Those proteins can be produced in large (up to grams) quantities and be sold at very competitive prices. Recently PLR has developed a pegylation service for either existing, provided or custom made proteins. Furthermore PLR is the ONLY company selling leptin antagonists (mono-pegylated and non-pegylated) and mono-pegylated leptins.PLR was founded without any major investments and its capital is based on the existing and novel expression plasmids, and the know-how of Prof. Gertler.
CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing. Our revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body. This makes our rhCollagen the ideal building block for regenerative medicine. Leveraging on the unique properties of rhCollagen and biomaterial know-how, we are developing a pipeline of products aimed at 3D bioprinting of tissues and organs and medical aesthetics.
We develop plant technologies to improve global sustainability. Our technologies are applicable to the forestry, biofuels, biochemical and biomaterial sectors. We have fully integrated operations from discovery, through regulatory to commercialization, coupled to germplasm access and market channels. Our key crop is sub-tropical eucalyptus. Our activities are centered at our corporate and R&D facilities in Brazil and Israel.
Forsea has a disruptive platform technology to produce cultivated seafood. The company aims to use its know how for nourishing the world with delicious, high-quality seafood while securing ocean health & wealth.